Mimedx Group, Inc. SEC filings MDXG

Mimedx Group, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 5, 2012. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Mimedx Group, Inc. SEC filings
Form Description Filed Period
425 Filing Oct 28, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Oct 28, 2026 Oct 28, 2026
10-Q Quarterly report Oct 28, 2026 Sep 30, 2026
425 Current report Oct 16, 2026 —
8-K Current report
Other events
Oct 16, 2026 Oct 15, 2026
EFFECT Filing Sep 4, 2026 —
424B3 Prospectus Sep 4, 2026 —
S-4 Registration for a merger or exchange Aug 25, 2026 —
425 Filing Aug 11, 2026 —
8-K/A Amended current report
Material agreement, Regulation FD disclosure
Aug 11, 2026 Jul 29, 2026
425 Form 425 Jul 30, 2026 —
425 Form 425 Jul 30, 2026 —
425 Form 425 Jul 29, 2026 —
425 Form 425 Jul 29, 2026 —
425 Filing Jul 29, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Jul 29, 2026 Jul 29, 2026
425 Filing Jul 29, 2026 —
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jul 29, 2026 Jul 29, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 16, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
DEFA14A Additional proxy material Apr 29, 2026 —
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 29, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Apr 29, 2026 Apr 29, 2026
10-Q Quarterly report Apr 29, 2026 Mar 31, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 16, 2026 Apr 14, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Feb 25, 2026 Feb 25, 2026
10-K Annual report Feb 25, 2026 Dec 31, 2025
4 Insider transaction Feb 18, 2026 Feb 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Nov 10, 2025 Nov 6, 2025
144 Notice of proposed sale Nov 6, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Oct 29, 2025 Oct 29, 2025
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure
Sep 3, 2025 Sep 3, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jul 30, 2025 Jul 30, 2025
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
S-8 Employee stock plan registration Jul 28, 2025 —
4 Insider transaction Jul 7, 2025 Jul 3, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
4 Insider transaction Jun 23, 2025 Jun 18, 2025
8-K Current report
Shareholder vote results
Jun 20, 2025 Jun 18, 2025
ARS Annual report to shareholders May 23, 2025 Dec 31, 2024
DEFA14A Additional proxy material May 23, 2025 —
4 Insider transaction May 16, 2025 May 8, 2025
8-K Current report
Regulation FD disclosure
May 13, 2025 May 13, 2025
4 Insider transaction May 5, 2025 May 2, 2025
DEF 14A Proxy statement Apr 30, 2025 Jun 18, 2025
10-Q Quarterly report Apr 30, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Apr 30, 2025 Apr 30, 2025
4 Insider transaction Apr 25, 2025 Apr 23, 2025
4 Insider transaction Apr 10, 2025 Apr 8, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Mar 20, 2025 Mar 17, 2025
4 Insider transaction Mar 14, 2025 Mar 13, 2025
4 Insider transaction Mar 14, 2025 Mar 13, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
144 Notice of proposed sale Mar 10, 2025 —
4 Insider transaction Mar 5, 2025 Feb 28, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
8-K Current report
Regulation FD disclosure
Feb 27, 2025 Feb 27, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 26, 2025 Feb 26, 2025
10-K Annual report Feb 26, 2025 Dec 31, 2024
4 Insider transaction Feb 18, 2025 Feb 13, 2025
8-K Current report
Regulation FD disclosure
Jan 14, 2025 Jan 14, 2025
8-K Current report
Material agreement
Dec 16, 2024 Dec 11, 2024
4 Insider transaction Dec 13, 2024 Dec 11, 2024
8-K Current report
Regulation FD disclosure
Nov 18, 2024 Nov 18, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
SC 13G Ownership over 5% (passive) Nov 7, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Oct 30, 2024 Oct 30, 2024
10-Q Quarterly report Oct 30, 2024 Sep 30, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 22, 2024 —
144 Notice of proposed sale Oct 10, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Jul 31, 2024 Jul 31, 2024
10-Q Quarterly report Jul 31, 2024 Jun 30, 2024
4 Insider transaction Jul 10, 2024 Jul 8, 2024
3 Initial insider ownership Jul 3, 2024 Jun 24, 2024
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
4 Insider transaction Jun 6, 2024 Jun 5, 2024
UPLOAD Letter from the SEC Jun 4, 2024 —
CORRESP Letter to the SEC May 24, 2024 —
UPLOAD Letter from the SEC May 10, 2024 —
4 Insider transaction May 9, 2024 May 8, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Apr 30, 2024 Apr 30, 2024
10-Q Quarterly report Apr 30, 2024 Mar 31, 2024
4 Insider transaction Apr 24, 2024 Apr 23, 2024
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Jun 5, 2024
4 Insider transaction Apr 10, 2024 Apr 8, 2024
8-K Current report
Regulation FD disclosure
Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 18, 2024 Mar 1, 2024
3 Initial insider ownership Mar 18, 2024 Mar 1, 2024
4 Insider transaction Mar 15, 2024 Mar 13, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
4 Insider transaction Mar 5, 2024 Mar 1, 2024
8-K Current report
Officer or director change
Mar 4, 2024 Feb 29, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 28, 2024 Feb 28, 2024
10-K Annual report Feb 28, 2024 Dec 31, 2023
4 Insider transaction Feb 21, 2024 Feb 16, 2024
144 Notice of proposed sale Feb 20, 2024 —
144 Notice of proposed sale Feb 16, 2024 —
4 Insider transaction Feb 16, 2024 Feb 14, 2024
144 Notice of proposed sale Feb 15, 2024 —
144 Notice of proposed sale Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 25, 2024 —
8-K Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
Jan 22, 2024 Jan 19, 2024
8-K Current report
Other events
Dec 28, 2023 Dec 22, 2023
4 Insider transaction Dec 27, 2023 Dec 22, 2023
SC 13D/A Amended ownership over 5% (active) Dec 27, 2023 —
4 Insider transaction Nov 22, 2023 Nov 21, 2023
8-K Current report
Regulation FD disclosure
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Oct 30, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Oct 30, 2023 Oct 30, 2023
8-K Current report
Officer or director change
Sep 5, 2023 Sep 5, 2023
8-K Current report
Regulation FD disclosure
Sep 5, 2023 Sep 5, 2023
10-Q Quarterly report Aug 1, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 1, 2023 Aug 1, 2023
S-8 Employee stock plan registration Jul 25, 2023 —
S-8 Employee stock plan registration Jul 25, 2023 —
4 Insider transaction Jul 6, 2023 Jul 5, 2023
3 Initial insider ownership Jul 6, 2023 Jul 5, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 5, 2023 Jul 5, 2023
4 Insider transaction Jun 26, 2023 Jun 22, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 20, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
4 Insider transaction Jun 15, 2023 Jun 13, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 14, 2023 Jun 13, 2023
4 Insider transaction May 17, 2023 May 15, 2023
144 Notice of proposed sale May 16, 2023 —
144 Notice of proposed sale May 15, 2023 —
DEF 14A Proxy statement May 15, 2023 —
4 Insider transaction May 12, 2023 May 10, 2023
4 Insider transaction May 12, 2023 May 10, 2023
4 Insider transaction May 12, 2023 May 10, 2023
4 Insider transaction May 12, 2023 May 10, 2023
144 Notice of proposed sale May 10, 2023 —
144 Notice of proposed sale May 10, 2023 —
144 Notice of proposed sale May 10, 2023 —
144 Notice of proposed sale May 10, 2023 —
4 Insider transaction May 9, 2023 May 4, 2023
PRE 14A Preliminary proxy statement May 4, 2023 May 4, 2023
144 Notice of proposed sale May 4, 2023 —
4 Insider transaction May 3, 2023 May 2, 2023
144 Notice of proposed sale May 2, 2023 —
8-K Current report
Results of operations, Regulation FD disclosure
May 2, 2023 May 2, 2023
10-Q Quarterly report May 2, 2023 Mar 31, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
4 Insider transaction Apr 27, 2023 Apr 25, 2023
4 Insider transaction Apr 27, 2023 Apr 25, 2023
4 Insider transaction Apr 27, 2023 Apr 25, 2023
4 Insider transaction Apr 27, 2023 Apr 25, 2023
144 Notice of proposed sale Apr 25, 2023 —
144 Notice of proposed sale Apr 25, 2023 —
144 Notice of proposed sale Apr 25, 2023 —
144 Notice of proposed sale Apr 25, 2023 —
4 Insider transaction Apr 13, 2023 Apr 11, 2023
4 Insider transaction Apr 13, 2023 Apr 11, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MDXG (Nasdaq)
Fiscal year ends
December 31
Headquarters
Marietta, GA
SEC filer status
Large accelerated filer
SEC CIK
1376339
Former names
Alynx, Co. (until Apr 2, 2008)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.